Cibc World Markets Corp Acquires New Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Cibc World Markets Corp bought a new position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 19,338 shares of the biotechnology company’s stock, valued at approximately $145,000. Several other hedge funds have also added […]
